Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers November 22, 2017
Pharmacy Choice - News - Front Page Healthcare News - November 22, 2017

Pharmacy News

 Front Page Healthcare News
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

11/22/17 - "Biocompatible Self-Lubricating Polymer Compositions and Their Use in Medical and Surgical Devices" in Patent Application Approval Process (USPTO...
"Biocompatible Self-Lubricating Polymer Compositions and Their Use in Medical and Surgical Devices" in Patent Application Approval Process. By a News Reporter-Staff News Editor at Biotech Week A patent application by the inventors Guo, Xiaoping; Stehr, Richard E., filed on May 12, 2017, was made available online on November 9, 2017, according to
11/22/17 - "Crystalline Form of a Substituted Quinoline Compound and Pharmaceutical Compositions Thereof" in Patent Application Approval Process (USPTO...
"Crystalline Form of a Substituted Quinoline Compound and Pharmaceutical Compositions Thereof" in Patent Application Approval Process. By a News Reporter-Staff News Editor at Biotech Week A patent application by the inventors Xi, Ning; Sun, Mingming, filed on November 12, 2016, was made available online on November 9, 2017, according to news repo
11/22/17 - "Treatment of Erectile Dysfunction and Other Indications" in Patent Application Approval Process (USPTO 20170312288)
By a News Reporter-Staff News Editor at Biotech Week A patent application by the inventor Fossel, Eric T., filed on July 18, 2017, was made available online on November 9, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application is assigned to Strategic Science& Technologies LLC. Curre
11/22/17 - AAPS President Attends National Physicians Council for Healthcare Policy Meeting D.C.
Albert L. Fisher, M.D., of Oshkosh, Wisconsin, represented the Association of American Physicians and Surgeons at the National Physicians Council for Healthcare Policy in Washington, D.C., Nov 4-6. Presentations showed how this model is not only burdensome and costly, but a serious threat to patient privacy, Dr. Fisher reported. Dr. Fisher spoke ab
11/22/17 - Acorda axes Parkinsons drug after trial deaths [All Iraq News Agency (AIN)]
Acorda Therapeutics has abandoned development of its Parkinsons drug, tozadenant, just days after putting trials on hold following a series of patient deaths. Based in New York state, Acorda said it made the decision after finding new information from phase 3 studies, related to the previously disclosed safety issues with agranulocytosis a lack of
11/22/17 - Allergic Reaction: Allergens Cause Dangerous Spike in FDA Recalled Food Units in Q3
By a News Reporter-Staff News Editor at Immunotherapy Weekly Recalled FDA food units increased 19 percent to 106.6 million in the third quarter of 2017- higher than 20 of the last 22 quarters- and public health risks rose sharply due to a spike in undeclared food allergens found in food products, according to the Q3 2017 Recall Index from Stericy
11/22/17 - Analysts: Regulators Unlikely To Oppose Aetna-CVS Deal [The Hartford Courant]
Nov. 21 An acquisition of Aetna Inc. by CVS Health Corp. may meet little resistance from federal regulators under the Trump administration, speeding the deal toward completion, two analysts say. Aetna may have to divest itself of $7.7 million in Medicare Part D customers to avoid federal antitrust concerns, Ana Gupte, an analyst at Leerink, said
11/22/17 - Biologics Safety Testing Market Is Estimated to Represent US $4.36 Bn During 2017-2022: Testing the safety of these biologics is critical for avoiding the inadvertent inclusion of unknown entities in drug manufacturing system.
A recently published report by Persistence Market Research projects that the global market for biologics safety testing will soar at a robust CAGR of 8.8% over the forecast period, 2017-2022. The report anticipates that approx. According to the report, North America will remain at the forefront of global expansion of biologics safety testing market
11/22/17 - CD Antigen Cancer Therapy Market Outlook & Clinical Trials Insight 2023 - Research and Markets
The "CD Antigen Cancer Therapy Market Outlook& Clinical Trials Insight 2023" report has been added to Research and Markets' offering. CD Antigen Cancer Therapy Market Outlook& Clinical Trials Insight 2023 report gives comprehensive insight into multiple clinical and non-clinical issues related to emergence and development of global CD Antigen cance
11/22/17 - Clinical Alarm Management Market Is Growing at Significant Rate by 2027 End: Hospitals and ambulatory surgical centres are the largest end-users in the clinical alarm management market and should remain so for the foreseeable future.
Valley Cottage, NY 11/21/2017 Clinical alarm management solutions are adopted by hospitals and ambulatory surgical centres to manage and respond to clinical alarms as and when they arise to minimize alarm fatigue. The clinical alarm management market is anticipated to push past a value of US$ 4 billion by end 2027.. The solutions component co
11/22/17 - Clinical Laboratory Services Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025
Global Clinical Laboratory Services Market: Scope and Methodology. This report on the global clinical laboratory services market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments.Read the f
11/22/17 - Concordia hiked drug price by 6,000%, says UK watchdog [T-break Tech (Middle East)]
Concordia has denied the claims, saying the pricing of the tablets has been conducted openly and transparently with the UKs Department of Health for the last decade. A company spokesperson added: Over that time, significant investment has been made in this medicine to ensure its continued availability for patients in the UK, to the specifications r
11/22/17 - CROs, pharma to increase staff dedicated to real world data collection by 25%, Tufts report [Arab Finance (Egypt)]
The industry is expected to use an increasing amount of real world evidence, including social media data, which will be used to support new drug applications, according to a recent Tufts report. With the passage of the 21st Century Cures Act passed in December 2016, the US Food and Drug Administration was required to develop a framework and guidanc
11/22/17 - Debiopharm International SA Launches Clinical Trials Website: patients.debiopharm.com
LAUSANNE, Switzerland, November 22, 2017/ PRNewswire/. The website provides patients and their caregivers with helpful information on Debiopharm's clinical trials and studies. Debiopharm's main therapeutic areas are oncology and infectious diseases.
11/22/17 - FDA pushes companies to develop opioids that resist abuse
The Food and Drug Administration issued guidance Tuesday to push drugmakers to craft cheaper generic painkillers that are more difficult to snort, inject or otherwise abuse than standard opioids. But we also know a significant barrier to use can be price, " Dr. Gottlieb said. Senate Democrats want Mr. Trump to dedicate $45 billion in taxpayer fundi
11/22/17 - Federal Register Table of Contents
Table of Contents Office of the Federal Register Agriculture Department NOTICES Agency Information Collection Activities; Proposals, Submissions, and Approvals, 55553 Bureau of Consumer Financial Protection RULES Arbitration Agreements, 55500 Centers for Disease Control and Prevention NOTICES Agency Information Collection Activities; Proposals,...
11/22/17 - Fuse Medical, Inc. Signs Non-Binding Letter of Intent to Purchase all of the Outstanding Membership Units of CPM Medical Consultants, LLC
By a News Reporter-Staff News Editor at Biotech Week Fuse Medical, Inc. announced that it signed a non-binding Letter of Intent to purchase all of the outstanding membership units of CPM Medical Consultants, LLC, a privately-owned national distributor of medical device implants and biologics. CPM is owned and controlled by the Company's Chairman
11/22/17 - Future Scope of Allergic Rhinitis market | World Major Key Players survey with 2023 Forecast
Market Research Future has a half cooked research report on global allergic rhinitis market. This market is growing at an average rate and is expected to show similar trends till 2023.. Hay fever is another name for allergic rhinitis which is a nose related disease.
11/22/17 - General Principles for Evaluating the Abuse Deterrence of Generic Solid Oral Opioid Drug Products; Guidance for Industry; Availability
SUMMARY: The Food and Drug Administration is announcing the availability of a guidance for industry entitled "General Principles for Evaluating the Abuse Deterrence of Generic Solid Oral Opioid Drug Products." The guidance recommends studies, including comparative in vitro and pharmacokinetic studies, that a potential ANDA applicant should conduct
11/22/17 - Global Heart Valve Devices Market forecast 2017-2025 detailed in new research report by Credence Research
The global heart valve devices market was valued at US$ 4,945 Mn in 2016, and is expected to reach US$ 13,377.9 Mn by 2025, expanding at a CAGR of 10.6% from 2017 to 2025.. According to the latest market report published by Credence Research, Inc. "Heart Valve Devices Market- Growth, Future Prospects, and Competitive Analysis, 2017- 2025," the glob
11/22/17 - Global Telemedicine Market 2017 Company Profiles, Size, Share, Growth, Trends, Developments, Analysis & Forecast to 2021
"\"Telemedicine Market\ "" WiseGuyReports.com adds Telemedicine Market 2017 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2021 reports to its database.. The global market for telemedicine is expected to grow at a significant pace during the forecasting period. By Specialty Global Telehospitals/Teleclinics Ma
11/22/17 - Global Telemedicine Market 2017 Size, Share, Development Status, Type and Application, Segmentation, Forecast by 2021
WiseGuyReports.com adds Telemedicine Market 2017 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2021 reports to its database.. PUNE, INDIA, November 22, 2017/ EINPresswire.com/ Telemedicine Market: Executive Summary The global market for telemedicine is expected to grow at a significant pace during the fore
11/22/17 - Indian Medical Tourism Market 2017 Share, Trend, Segmentation, Opportunities and Forecast to 2022
The Indian government has removed many visa restrictions and introduced a visa-on-arrival scheme for medical tourists from selected countries; this allows foreign nationals to stay in India for 30 days for medical reasons and can even get a visa of up to 1 year depending upon treatment requirements. In the Indian medical tourism market, Bangladesh,
11/22/17 - Ionis Licenses Novel Antisense Drug for the Treatment of Centronuclear Myopathy to Dynacure
By a News Reporter-Staff News Editor at Biotech Week Ionis Pharmaceuticals, Inc. and Dynacure announced that Dynacure has licensed IONIS-DNM2-2.5Rx, a Generation 2.5 antisense drug targeting dynamin 2 for the treatment of centronuclear myopathy, for which Ionis earned a $5 million license fee in the form of Dynacure equity. We are pleased that Dy
11/22/17 - Janssen Announces U.S. FDA Approval of First and Only Complete, Single-Pill, Two-Drug Regimen, JULUCA (Dolutegravir and Rilpivirine), for the Treatment of HIV-1 Infection
Janssen Therapeutics, Division of Janssen Products, LP, today announced that the U.S. Food and Drug Administration has approved JULUCA (R), the first, complete, single-pill, two-drug regimen for the treatment of human immunodeficiency virus type 1 infection in certain adults living with the disease who are virologically suppressed. JULUCA (R) is a
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415